Covariate | Study count | Co-efficient | 95% CI | p value |
---|---|---|---|---|
Clamp time* | 8 | 0.0556 | 0.0334–0.0778 |  < 0.0001 |
Transfusion Units* | 8 | 0.6928 | 0.3393–1.0463 | 0.0001 |
Study year | 12 | − 0.037 | − 0.1131 to 0.0390 | 0.3402 |
Age | 10 | 0.0249 | − 0.0647 to 0.1145 | 0.5864 |
Sex (Male) | 10 | − 2.7767 | − 10.3351 to 4.7817 | 0.4715 |
Bilirubin threshold | 12 | 1.0256 | − 0.6223 to 2.6734 | 0.2225 |
Bilirubin monitoring period | 7 | 0.1577 | − 0.1212 to 0.4365 | 0.2678 |
CPB time | 11 | 0.0159 | − 0.0108 to 0.0427 | 0.2431 |
CABG proportion | 12 | − 0.2853 | − 2.8252 to 2.2547 | 0.8258 |
Pre-operative liver disease | 5 | − 7.4876 | − 16.3865 to 1.4113 | 0.0991 |